These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 8687106

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497
    [Abstract] [Full Text] [Related]

  • 5. Wilms tumor and the WT1 gene.
    Lee SB, Haber DA.
    Exp Cell Res; 2001 Mar 10; 264(1):74-99. PubMed ID: 11237525
    [Abstract] [Full Text] [Related]

  • 6. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF.
    Oncogene; 1995 Feb 02; 10(3):415-22. PubMed ID: 7845666
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.
    Brenner B, Wildhardt G, Schneider S, Royer-Pokora B.
    Oncogene; 1992 Jul 02; 7(7):1431-3. PubMed ID: 1320246
    [Abstract] [Full Text] [Related]

  • 9. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF.
    Clin Cancer Res; 1997 Dec 02; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [Abstract] [Full Text] [Related]

  • 10. The role of Wilms' tumor genes.
    Hirose M.
    J Med Invest; 1999 Aug 02; 46(3-4):130-40. PubMed ID: 10687307
    [Abstract] [Full Text] [Related]

  • 11. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F, Barilla KC, Hamilton TB, Iskandar M, Romaniuk PJ.
    Biochemistry; 1996 Sep 17; 35(37):12070-6. PubMed ID: 8810912
    [Abstract] [Full Text] [Related]

  • 12. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM, Hinkes MT, Bernfield M, Rauscher FJ.
    Oncogene; 1996 Oct 17; 13(8):1789-99. PubMed ID: 8895526
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of p21 by the Wilms' tumor suppressor gene WT1.
    Englert C, Maheswaran S, Garvin AJ, Kreidberg J, Haber DA.
    Cancer Res; 1997 Apr 15; 57(8):1429-34. PubMed ID: 9108440
    [Abstract] [Full Text] [Related]

  • 17. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
    Dallosso AR, Hancock AL, Brown KW, Williams AC, Jackson S, Malik K.
    Hum Mol Genet; 2004 Feb 15; 13(4):405-15. PubMed ID: 14681303
    [Abstract] [Full Text] [Related]

  • 18. Genotype/phenotype correlations in Wilms' tumor.
    Huff V.
    Med Pediatr Oncol; 1996 Nov 15; 27(5):408-14. PubMed ID: 8827067
    [Abstract] [Full Text] [Related]

  • 19. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S, Tomlinson G, Nisen P, Haber DA.
    Cancer Res; 1993 Oct 15; 53(20):4757-60. PubMed ID: 8402654
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.